 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
SECOND REGULAR SESSION-2020
Legislative Document No. 2059
H.P. 1463 House of  Representatives, January 16, 2020
An Act  To Clarify the Provision  for Care  of Infants after  Birth
Submitted by the Department of  Health and Human  Services pursuant  to Joint Rule 203.
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative HYMANSON of York.

Page 1 - 129LR3007(01)-11Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  22 MRSA ยง1531, sub-ยง1, as enacted by PL 2019, c. 426, ยง1, is amended 
3to read:
41.  Prophylactic ophthalmic ointment and reporting requirement.  Every 
5physician, midwife or nurse in charge shall instill or cause to be instilled into the eyes of 
6an infant within 24 hours after its birth prophylactic ophthalmic ointment prescribed by 
7the department and provided without cost by the department.  If one or both eyes of an 
8infant become reddened or inflamed at any time within 4 weeks after birth, the midwife, 
9nurse or person having charge of the infant shall report the condition of the eyes at once 
10to a physician the infant's primary care provider licensed under Title 32, chapter 36 or 48.
11Sec. 2.  PL 2019, c. 426, ยง2 is amended to read:
12Sec. 2.  Department of Health and Human Services to amend develop 
13form.  The Department of Health and Human Services shall amend its newborn blood 
14spot screening refusal form to include a section permitting develop an ophthalmic 
15ointment and vitamin K injection refusal form that permits a parent to refuse the 
16prophylactic ophthalmic ointment or vitamin K injection required under the Maine 
17Revised Statutes, Title 22, section 1531 for the infant of that parent.
18SUMMARY
19This bill makes the following changes to the laws governing the administration of 
20prophylactic ophthalmic ointment and vitamin K injections to infants:
211.  It specifies that the incidence of inflamed or reddened eyes in an infant be reported 
22to the infant's primary care provider rather than to an unspecified physician;
232.  It removes language specifying that the ophthalmic ointment is prescribed and 
24provided without cost by the Department of Health and Human Services; and
253.  It requires the department to develop a form to be used by a parent wishing to 
26refuse the prophylactic ophthalmic ointment or vitamin K injection that is separate from 
27the newborn blood spot screening refusal form.
